Obermatt
See Similar Stocks →

CONMED

NYQ:CNMD · US2074101013
Health Care Equipment & SuppliesSmall

360

44
EV / EBIT85
Price / Owner Earnings47
Owner Earnings Yield88
Dividend Yield1
Price/Sales89
EV / Gross Profit78
Price/Book76
Return on Capital67
Cash Return on Capital67
Return on Equity65
EBIT Margin71
Gross Profitability44
Cash Conversion76
Accruals51
Owner Earnings Margin74
Sales growth15
Profit Growth72
Long-Term EPS Growth59
Owner Earnings Growth29
Reinvestment22
Price momentum22
Debt load38
Refinancing88
Debt Payback17
Liquidity70
Analyst ratings1
Opinion Changes50
Price Target Upside20
Market mood17
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

CONMED clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNYSE
Founded1970
Employees2,139
Websiteconmed.com
ISINUS2074101013
Last UpdateApr 2, 2026
Indices
D.J. US Medical Equipment
Themes
CardiovascularHealth DiagnosticsBiomedical EngineeringInjection MoldingGastroenterologyOrthopaedicsSurgeryInformation TechnologyMedicalMedical Device

Description

CONMED Corporation (CONMED) operates as a medical technology company that provides devices and equipment for surgical procedures. The company’s products are used by surgeons and other healthcare professionals in a variety of specialties, including o…

Analysis

Bargain bin

CONMED Corporation is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is attractive. The owner-earnings multiple stands at 9.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around -4% a year, against analyst forecasts of 5%. The price, in other words, assumes less than the experts do.

Growth is tepid; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
29
2023202420252026

All-time high

98

Mar 2025

All-time low

29

Jun 2026

Average rank

60

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
89
68
56
63
Price/Earnings
56
77
34
29
Price/Book
76
59
46
52
Dividend Yield
1
94
91
83
Value (overall)
80
99
96
67

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare CONMED with its peers
AtriCure
NMQ:ATRC
75
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Globus Medical
NYQ:GMED
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Apyx Medical
NSQ:APYX
34
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
AxoGen
NAQ:AXGN
43
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SI-BONE
NMQ:SIBN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →